T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions.
- DOI
- 10.1111/ejh.70063
- Published
- 2026 Feb
- Container
- European journal of haematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/ejh.70063,
title = {T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions.},
author = {Caserta S and Martino EA and Vigna E and Bruzzese A and Amodio N and Lucia E and Olivito V and Labanca C and Mendicino F and Morabito F and Gentile M},
year = {2026},
journal = {European journal of haematology},
doi = {10.1111/ejh.70063},
url = {https://doi.org/10.1111/ejh.70063}
}RIS
TY - JOUR TI - T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions. AU - Caserta S AU - Martino EA AU - Vigna E AU - Bruzzese A AU - Amodio N AU - Lucia E AU - Olivito V AU - Labanca C AU - Mendicino F AU - Morabito F AU - Gentile M PY - 2026 JO - European journal of haematology DO - 10.1111/ejh.70063 UR - https://doi.org/10.1111/ejh.70063 ER -
APA
S, C., EA, M., E, V., A, B., N, A., E, L., V, O., C, L., F, M., F, M., & M, G. (2026). T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions.. European journal of haematology. https://doi.org/10.1111/ejh.70063
Source records
- pubmed · retrieved 2026-09-26T06:23:45.723Z